DyeVert™ PLUS Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
Moderate and severe chronic kidney disease
Diabetes
Older age
Heart failure
Dye reduction
DyeVert™ PLUS is the only FDA cleared product with the claim of reduced dye delivery to the patient without impacting image quality.
Proven results
DyeVert™ PLUS clinical results show over 40% average reduction in contrast dosage injected to the patient.1
Real-time dose monitoring
DyeVert™ PLUS module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.
1 Desch, S. A Novel System to Save Contrast During Coronary Angiography – The DyeVertTM Randomized Controlled Trial. Presented abstract at Transcatheter Cardiovascular Therapeutics Annual Meeting, Washington, DC, October 2016.
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS reduces contrast amount without compromising image quality. See for yourself.
Without contrast reduction
With DyeVert™ Plus contrast reduction
Real-Time Monitoring
Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert PLUS technology.
The DyeVert Plus Technology
DyeVert™ PLUS contrast monitoring system is easy to use and incorporate into common cath-lab procedures.